Hot Stocks: ARO, PPHM, PACB, URRE, ISIS

Houston, TX -- (SBWIRE) -- 01/10/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Aeropostale, Inc. (NYSE:ARO) shares fell 9.42% to $12.10 after the company said demand had weakened during the holiday selling period, while rival American Eagle Outfitters Inc said sales had risen and post-Christmas selling was strong. The company announced that based on the lower than expected sales and margins for the quarter, the Company expects fourth quarter 2012 net earnings to be in the range of approximately $0.20 to $0.24 per diluted share, compared to its previously issued guidance of approximately $0.36 to $0.41 per diluted share. The revised earnings guidance does not include the impact of any potential store asset impairment charges. Analysts are expecting the Company to report EPS of $0.40 for fourth quarter of 2012.

How Should Investors Trade ARO After The Recent Volatile Moves? Find Out Here

Peregrine Pharmaceuticals (NASDAQ:PPHM) shares gained 5.83% to $2.18 after the company, on Jan. 7, provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer (NSCLC) in 121 patients. The review was prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA.

Additionally, Roth Capital upgraded shares of PPHM from a neutral rating to a buy rating in a research report released on Jan. 9. Roth Capital currently has $2.70 price target on the stock.

Is PPHM Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Pacific Biosciences of California (NASDAQ:PACB) shares climbed 10.13% to $2.44. The 52 week trading range for the company is $1.06 - $5.27. The shares of the company fell 23% in the last one year. The company develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.

Is PACB Ready To Move Back To New Highs This Year? Find Out Here

Uranium Resources, Inc. (NASDAQ:URRE) shares increased 11.76% to $0.570 after the company announced the expansion and extension of its South Texas exploration agreement with Cameco Texas, Inc., a subsidiary of Power Resources, Inc., which is a subsidiary of Cameco Corporation ( CCJ). Additionally, the company signed an amendment to its uranium mining lease option in Kenedy County, Texas for the Tecolote tract, approximately 22,700 net acres that will be a part of the exploration program.

Can URRE Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares climbed 6.46% to $12.75. Ryan & Maniskas, LLP day before yesterday announces that a class action lawsuit has been filed in the United States District Court for United States District Court for the Southern District of California on behalf of all persons or entities that purchased the stock of Isis Pharmaceuticals, Inc. ("Isis Pharmaceuticals" or the "Company") (NASDAQ: ISIS) from March 29, 2012 through October 15, 2012, inclusive (the "Class Period").

How Should Investors Trade ISIS After The Recent Volatile Moves? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com